Integrated Filing — IndAS

General information about company
Scrip Code	540743
NSE Symbol	GODREJAGRO
MSEI Symbol	NOTLISTED
ISIN	INE850D01014
Name of company	Godrej Agrovet Limited
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	30-Apr-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	24-Apr-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	Agri Business
Start date and time of board meeting	30-Apr-2025   15:30:00
End date and time of board meeting	30-Apr-2025   17:08:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion
Whether the company has any related party?	Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?	Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public	NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.	NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)?	No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?	Yes
Latest Date on which RPT policy is updated	2025-01-31
Indicate Company website link for updated RPT policy of the Company	https://www.godrejagrovet.com/sustainability/codes-and-policies
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter?	No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity?	No
There is no default on Loans and Debt Securities

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	15498800000	70090700000
	Other income	34900000	1088800000
	Total income	15533700000	71179500000
2	Expenses
(a)	Cost of materials consumed	12250700000	53669000000
(b)	Purchases of stock-in-trade	213600000	1026800000
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	-320100000	-984400000
(d)	Employee benefit expense	776400000	3147400000
(e)	Finance costs	155000000	832500000
(f)	Depreciation, depletion and amortisation expense	313300000	1241300000
(f)	Other Expenses
1	Other expenses (Refer Note 7)	1277300000	5620000000
	Total other expenses	1277300000	5620000000
	Total expenses	14666200000	64552600000
3	Total profit before exceptional items and tax	867500000	6626900000
4	Exceptional items	0	0
5	Total profit before tax	867500000	6626900000
6	Tax expense
7	Current tax	154200000	1435500000
8	Deferred tax	32700000	165800000
9	Total tax expenses	186900000	1601300000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	680600000	5025600000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	680600000	5025600000
17	Other comprehensive income net of taxes	-43500000	16500000
18	Total Comprehensive Income for the period	637100000	5042100000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent
	Total comprehensive income for the period attributable to owners of parent non-controlling interests
21	Details of equity share capital
	Paid-up equity share capital	1922700000	1922700000
	Face value of equity share capital	10	10
27	Details of debt securities
22	Reserves excluding revaluation reserve		23810700000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	3.54	26.14
	Diluted earnings (loss) per share from continuing operations	3.54	26.13
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	3.54	26.14
	Diluted earnings (loss) per share from continuing and discontinued operations	3.54	26.13
24	Debt equity ratio	0.002	0.002
25	Debt service coverage ratio	0.0359	0.05
26	Interest service coverage ratio	0.066	0.0896
27	Disclosure of notes on financial results

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	12301000000
	Capital work-in-progress	350900000
	Investment property	0
	Goodwill	0
	Other intangible assets	148400000
	Intangible assets under development	27400000
	Biological assets other than bearer plants	538600000
	Investments accounted for using equity method	12701200000
	Non-current financial assets
	Non-current investments	164900000
	Trade receivables, non-current	0
	Loans, non-current	604400000
	Other non-current financial assets	302900000
	Total non-current financial assets	1072200000
	Deferred tax assets (net)	8500000
	Other non-current assets	937300000
	Total non-current assets	28085500000
2	Current assets
	Inventories	9618000000
	Current financial asset
	Current investments	0
	Trade receivables, current	3796300000
	Cash and cash equivalents	227400000
	Bank balance other than cash and cash equivalents	3500000
	Loans, current	205700000
	Other current financial assets	354000000
	Total current financial assets	4586900000
	Current tax assets (net)	0
	Other current assets	1442400000
	Total current assets	15647300000
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	43732800000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	1922700000
	Other equity	23810700000
	Total equity attributable to owners of parent	25733400000
	Non controlling interest
	Total equity	25733400000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	675000000
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	847500000
	Total non-current financial liabilities	1522500000
	Provisions, non-current	37200000
	Deferred tax liabilities (net)	729300000
	Deferred government grants, Non-current	0
	Other non-current liabilities	90500000
	Total non-current liabilities	2379500000
	Current liabilities
	Current financial liabilities
	Borrowings, current	4551500000
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	285600000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	6734200000
	Total Trade payable	7019800000
	Other current financial liabilities	1963800000
	Total current financial liabilities	13535100000
	Other current liabilities	1494300000
	Provisions, current	286700000
	Current tax liabilities (Net)	303800000
	Deferred government grants, Current	0
	Total current liabilities	15619900000
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	17999400000
	Total equity and liabilites	43732800000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Remeasurement of defined benefit liability	-15200000	-15700000
2	Changes in Fair Value of investment in Body Corporate	-43000000	37700000
	Total Amount of items that will not be reclassified to profit and loss	-58200000	22000000
2	Income tax relating to items that will not be reclassified to profit or loss	-14700000	5500000
3	Amount of items that will be reclassified to profit and loss
	Total Amount of items that will be reclassified to profit and loss
4	Income tax relating to items that will be reclassified to profit or loss	0	0
5	Total Other comprehensive income	-43500000	16500000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Audited
D	Nature of report standalone or consolidated			Standalone
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			6626900000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			832500000
	Adjustments for decrease (increase) in inventories			21300000
	Adjustments for decrease (increase) in trade receivables, current			-361100000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			0
	Adjustments for decrease (increase) in other non-current assets			-464600000
	Adjustments for other financial assets, non-current			0
	Adjustments for other financial assets, current			139100000
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			2551500000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			-121100000
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			1241300000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			0
	Adjustments for provisions, current			2500000
	Adjustments for provisions, non-current			0
	Adjustments for other financial liabilities, current			-161800000
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			4700000
	Adjustments for dividend income			673700000
	Adjustments for interest income			186000000
	Adjustments for share-based payments			21600000
	Adjustments for fair value losses (gains)			14900000
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			59400000
	Other adjustments to reconcile profit (loss)			0
	Other adjustments for non-cash items			0
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			2920500000
	Net cash flows from (used in) operations			9547400000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			1454700000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			8092700000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			0
	Other cash receipts from sales of equity or debt instruments of other entities			152000000
	Other cash payments to acquire equity or debt instruments of other entities			5276500000
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			39200000
	Purchase of property, plant and equipment			1418700000
	Proceeds from sales of investment property			0
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			980400000
	Cash receipts from repayment of advances and loans made to other parties			1952500000
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			673700000
	Interest received			203500000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) investing activities	-4654700000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			0
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			600000
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			55653300000
	Repayments of borrowings			56295900000
	Payments of lease liabilities			298100000
	Dividends paid			1922400000
	Interest paid			721700000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) financing activities			-3584200000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			-146200000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			0
	Net increase (decrease) in cash and cash equivalents			-146200000
	Cash and cash equivalents cash flow statement at beginning of period			373600000
	Cash and cash equivalents cash flow statement at end of period			227400000